Cimica et al., 2020 - Google Patents
Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine modelCimica et al., 2020
- Document ID
- 15013646211551317135
- Author
- Cimica V
- Williams S
- Adams-Fish D
- McMahon C
- Narayanan A
- Rashid S
- Stedman T
- Publication year
- Publication venue
- Biochemical and Biophysical Research Communications
External Links
Snippet
Zika virus (ZIKV) is a mosquito-borne flavivirus associated with Congenital Zika Syndrome (CZS), reflecting a wide range of congenital abnormalities in fetuses and infants infected with ZIKV before birth. ZIKV infections have also been associated with the neurological …
- 229960005486 vaccines 0 title abstract description 53
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Diamond et al. | Zika virus vaccine development: progress in the face of new challenges | |
| Lai et al. | Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody | |
| De Filette et al. | Recent progress in West Nile virus diagnosis and vaccination | |
| Rothman | Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms | |
| Simmons et al. | Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy | |
| Zhang et al. | Modified mRNA-LNP vaccines confer protection against experimental DENV-2 infection in mice | |
| Sukupolvi-Petty et al. | Type-and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes | |
| Apt et al. | Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen | |
| Goo et al. | The Zika virus envelope protein glycan loop regulates virion antigenicity | |
| Costa et al. | DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus | |
| Liang et al. | Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice | |
| US11578103B2 (en) | Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays | |
| Martín-Acebes et al. | A recombinant DNA vaccine protects mice deficient in the alpha/beta interferon receptor against lethal challenge with Usutu virus | |
| KR20130138789A (en) | Recombinant subunit dengue virus vaccine | |
| Boigard et al. | Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature | |
| Cimica et al. | Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine model | |
| Lazo et al. | A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus | |
| US11286502B2 (en) | ZIKA virus like particle (VLP) based vaccine and microneutralization assay | |
| Blair et al. | Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys | |
| WO2015197565A1 (en) | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection | |
| Yamanaka et al. | Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays | |
| CN111132692A (en) | Virus-like particles comprising Zika virus antigen | |
| De Lorenzo et al. | Zika virus-like particles bearing a covalent dimer of envelope protein protect mice from lethal challenge | |
| Shukla et al. | Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement | |
| He et al. | A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice |